| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Laryngeal adductor paralysis | 0.619 | 0.731 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | |||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
myomesin 2 | 0.570 | 0.692 | 7.0E-85 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
integrin subunit beta 2 | 0.444 | 0.923 | 5.1E-15 |
|
phenotype | 0.120 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
dihydrolipoamide dehydrogenase | 0.517 | 0.769 | 9.5E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
beta-1,3-glucuronyltransferase 1 | 0.494 | 0.769 | 0.14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ladinin 1 | 0.584 | 0.731 | 1.8E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
Rac family small GTPase 2 | 0.556 | 0.731 | 0.97 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2002 | 2002 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily A member 3 | 0.592 | 0.615 | 6.6E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
nuclear factor, interleukin 3 regulated | 0.633 | 0.615 | 0.82 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
mevalonate diphosphate decarboxylase | 0.568 | 0.769 | 2.7E-17 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2001 | 2008 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
purinergic receptor P2Y14 | 0.780 | 0.154 | 5.5E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 |